The Mary Kay Ash Foundation®, a 501(c)(3) nonprofit organization, which raises and distributes funds to invest in breakthrough cancer research to find cures for cancers affecting women and ending domestic violence against women, marks its 30th anniversary
On Saturday, May 30th, AEG employees came together to volunteer at the Little Tokyo Service Center's (LTSC) "pLAy Day" at the Terasaki Budokan, a free, inclusive community event bringing people of all ages together through movement, wellness, and connection.
Using GLP-1 agonist medications can improve health outcomes for a growing number of conditions including cardiovascular disease, type 2 diabetes, liver disease, and kidney disease. However, it’s no secret that lots of people take them primarily for weight loss.
Truist Foundation today announced the launch of its fourth Inspire Awards, a capacity-building grant program for nonprofit organizations across the markets Truist Bank serves. This year’s challenge aligns to Truist Foundation’s focus on creating career pathways
We often think of agricultural waste, such as crop residues, forestry byproducts, or even manure, as an end-of-the-line byproduct. But what if it were actually a valuable resource? Enter Biochar.
DP World has successfully achieved Green Marine recertification across four of its Canadian terminals, reinforcing its commitment to environmental stewardship and continuous improvement across port operations.
Learn how EHS professionals evaluate eLearning program options, from conducting training needs assessments to choosing the right LMS, delivery formats, and compliance training options.
Urbaneer and the Well Living Lab recently hosted a networking event showcasing plans for the Home Innovation Lab (HIL), an innovative residential home designed to demonstrate how research, technology, and human-centered design can support healthier living environments and aging
CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members— including the reintroduction of Zepbound® (tirzepatide) as a covered medication.
